Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303:333–40.

Article  CAS  PubMed  Google Scholar 

Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1–156.

Article  PubMed  Google Scholar 

Investigators AWGotA, Connolly S, Pogue J et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet (London, England) 2006;367:1903–12.

Grimaldi-Bensouda L, Le Heuzey JY, Ferrieres J, et al. Stroke prevention by anticoagulants in daily practice depending on atrial fibrillation pattern and clinical risk factors. Stroke. 2021;52:3121–31.

Article  CAS  PubMed  Google Scholar 

Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–42.

Article  CAS  PubMed  Google Scholar 

Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011;123:417–24.

Article  PubMed  Google Scholar 

Freeman JV, Varosy P, Price MJ, et al. The NCDR left atrial appendage occlusion registry. J Am Coll Cardiol. 2020;75:1503–18.

Article  PubMed  PubMed Central  Google Scholar 

Phillips KP, Walker DT, Humphries JA. Combined catheter ablation for atrial fibrillation and Watchman(R) left atrial appendage occlusion procedures: five-year experience. J Arrhythm. 2016;32:119–26.

Article  PubMed  Google Scholar 

Charate R, Ahmed A, Della Rocca DG, et al. Evaluation of multimodality LAA leak closure methods following incomplete occlusion: the LAA leak study. JACC Cardiovasc Interv. 2022;15:2158–70.

Article  PubMed  Google Scholar 

Di Biase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122:109–18.

Article  PubMed  Google Scholar 

Turagam MK, Lavu M, Afzal MR, et al. Catheter ablation for atrial fibrillation in patients with watchman left atrial appendage occlusion device: results from a multicenter registry. J Cardiovasc Electrophysiol. 2017;28:139–46.

Article  PubMed  Google Scholar 

Chen JJ, Chiu FC, Chang SN, et al. Impact of pre-existing left atrial appendage occluder on catheter ablation of atrial fibrillation. Heart. 2023;109:921–8.

Article  PubMed  Google Scholar 

Heeger CH, Rillig A, Lin T, et al. Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices. Heart Rhythm. 2015;12:1524–31.

Article  PubMed  Google Scholar 

Dukkipati SR, Kar S, Holmes DR, et al. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018;138:874–85.

Article  PubMed  Google Scholar 

Walker DT, Phillips KP. Left atrial catheter ablation subsequent to Watchman(R) left atrial appendage device implantation: a single centre experience. Europace. 2015;17:1402–6.

Article  PubMed  Google Scholar 

Wintgens LIS, Klaver MN, Swaans MJ, et al. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices. Europace. 2019;21:428–33.

Article  PubMed  Google Scholar 

Kar S, Hou D, Jones R, et al. Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model. JACC Cardiovasc Interv. 2014;7:801–9.

Article  PubMed  Google Scholar 

Valderrábano M, Peterson LE, Swarup V, et al. Effect of catheter ablation with vein of marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the VENUS randomized clinical trial. JAMA. 2020;324:1620–8.

Article  PubMed  Google Scholar 

Rodríguez-Mañero M, Schurmann P, Valderrábano M. Ligament and vein of Marshall: a therapeutic opportunity in atrial fibrillation. Heart Rhythm. 2016;13:593–601.

Article  PubMed  Google Scholar